Recombinant Hepatitis B vaccine (Sinovac Biotech)
重组乙型肝炎疫苗（汉逊酵母）（北京科兴生物）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant Hepatitis B vaccine (Sinovac Biotech)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSinovac Biotech Ltd
China Registration ClassN/A
Develop Information
Active CompaniesSinovac Biotech Co LtdSinovac Life Sciences Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A